Understand the Latest Regulatory Policy, Clinical Strategies, Patient Outreach and Commercialization Dynamics Impacting Orphan Drug Development.
This annual summit brings together industry stakeholders and key thought leaders in the rare disease and orphan drug development arena. Hear from the FDA on results from the “Science of Small Clinical Trials” eight week course, NORD, BioMarin Pharmaceuticals, Amicus Therapeutics and many more.
For more information or to register Call: 800-817-8601 (339-298-2100 international calls); Email: [email protected] or visit: www.cbinet.com/raredisease.
Special offer to CheckOrphan Subscribers: Register with Promo Code: JCM499 and Save $300 off the Standard Rate. (Cannot be combined with other discounts or used toward a current registration.)